{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:14:05Z","timestamp":1791540845150,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.healun.2025.04.012","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T21:03:19Z","timestamp":1745701399000},"page":"1331-1338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low-dose apixaban in HeartMate 3 LVAD patients, interim analysis of the ApixiVAD trial, a randomized controlled study"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7660-6258","authenticated-orcid":false,"given":"Bruno","family":"Schnegg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Deveza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-6773","authenticated-orcid":false,"given":"Sumita","family":"Barua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Chavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1377-6372","authenticated-orcid":false,"given":"Phillip","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Capek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6356-2284","authenticated-orcid":false,"given":"Jolie","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Pavlicek-Bahlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Xourgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7402-2056","authenticated-orcid":false,"given":"Alexandra","family":"Neagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-3194","authenticated-orcid":false,"given":"Kathrin","family":"Z\u00fcrcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-7119","authenticated-orcid":false,"given":"Kavitha","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-9343","authenticated-orcid":false,"given":"Matthias","family":"Siepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0081-8518","authenticated-orcid":false,"given":"Lukas","family":"Hunziker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jansz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-2825","authenticated-orcid":false,"given":"Peter","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4036-1890","authenticated-orcid":false,"given":"Christopher","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2025.04.012_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.healun.2017.12.003","article-title":"Left ventricular assist devices versus medical management in ambulatory heart failure patients: an analysis of INTERMACS profiles 4 and 5 to 7 from the ROADMAP study","volume":"37","author":"Shah","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2025.04.012_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.healun.2018.09.021","article-title":"Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry","volume":"38","author":"Ambardekar","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"S1","key":"10.1016\/j.healun.2025.04.012_bib3","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1111\/jth.12961","article-title":"Medical device-induced thrombosis: what causes it and how can we prevent it?","volume":"13","author":"Jaffer","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.healun.2025.04.012_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/aor.13116","article-title":"Meta-analysis of time in therapeutic range in continuous-flow left ventricular assist device patients receiving warfarin","volume":"42","author":"Martinez","year":"2018","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2025.04.012_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MAT.0000000000001572","article-title":"Time in therapeutic range significantly impacts survival and adverse events in destination therapy patients","volume":"68","author":"Macaluso","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2025.04.012_bib6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cardfail.2024.07.024","article-title":"Antithrombotic strategies with left ventricular assist devices","volume":"30","author":"Cikes","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2025.04.012_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2025.04.012_bib8","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an On-X mechanical aortic valve","volume":"2","author":"Wang","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.healun.2025.04.012_bib9","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2025.04.012_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jchf.2024.04.013","article-title":"Evaluation of the hemocompatibility of the direct oral anticoagulant apixaban in left ventricular assist devices:\u00a0the DOAC LVAD study","volume":"12","author":"Shah","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2025.04.012_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.124.069726","article-title":"A prospective randomized trial of direct oral anticoagulant therapy with a fully magnetically levitated LVAD: the DOT-HM3 study","volume":"150","author":"Netuka","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2025.04.012_bib12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.cardfail.2024.05.005","article-title":"Direct oral anticoagulant therapy with a fully magnetically levitated LVAD and bridging to heart transplantation: a DOT-HM3 study analysis","volume":"30","author":"Netuka","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2025.04.012_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.healun.2018.03.002","article-title":"Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study","volume":"37","author":"Netuka","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2025.04.012_bib14","article-title":"Ex vivo assessment of different oral anticoagulant regimens on pump thrombosis in a HeartWare Ventricular Assist Device","volume":"14","author":"Rao","year":"2021","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.healun.2025.04.012_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2025.04.012_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.healun.2024.11.003","article-title":"Apixaban plasma levels in patients with HeartMate 3 support","volume":"44","author":"Van Edom","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2025.04.012_bib17","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ehf2.14782","article-title":"Apixaban in bridge to transplant and destination LVAD - rationale and study design: the ApixiVAD trial","volume":"11","author":"Schnegg","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.healun.2025.04.012_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"issue":"Suppl 4","key":"10.1016\/j.healun.2025.04.012_bib19","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.healun.2021.01.1950","article-title":"Maximising time in therapeutic range with vitamin K antagonists in LVAD patients","volume":"40","author":"Schnegg","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.healun.2025.04.012_bib20","doi-asserted-by":"crossref","first-page":"S362","DOI":"10.1016\/j.healun.2023.02.842","article-title":"(829) Self-management if anticoagulation in patients with LVAD, is there a cost to anticoagulation on target?","volume":"42","author":"Schnegg","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2025.04.012_bib21","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.3390\/jcm11195889","article-title":"Removal of apixaban during emergency cardiac surgery using hemoadsorption with a porous polymer bead sorbent","volume":"11","author":"Hassan","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.healun.2025.04.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100165","article-title":"CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation","volume":"7","author":"Frering","year":"2025","journal-title":"JHLT Open"},{"key":"10.1016\/j.healun.2025.04.012_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0267659120967827","article-title":"Cytosorb\u00ae hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report","volume":"36","author":"Mendes","year":"2021","journal-title":"Perfusion"},{"key":"10.1016\/j.healun.2025.04.012_bib24","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.jvca.2022.01.038","article-title":"In vitro apixaban removal by CytoSorb whole blood adsorber: an experimental study","volume":"36","author":"R\u00f8ed-Undlien","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.healun.2025.04.012_bib25","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.4103\/sja.SJA_559_18","article-title":"The CONSORT statement","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.healun.2025.04.012_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.23204","article-title":"Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: the ARIES-HM3 randomized clinical trial","author":"Mehra","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2025.04.012_bib27","first-page":"26","article-title":"Reducing antithrombotic-related bleeding risk in urgent and emergency cardiac surgery","volume":"28","author":"Harky","year":"2021","journal-title":"Br J Cardiol"},{"issue":"Suppl 4","key":"10.1016\/j.healun.2025.04.012_bib28","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/j.healun.2021.01.580","article-title":"Bloody Transplants! Impact of prior sternotomy on transfusion rate in heart transplantation","volume":"40","author":"Schnegg","year":"2021","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249825019217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249825019217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:34:55Z","timestamp":1774427695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249825019217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1053249825019217"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2025.04.012","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose apixaban in HeartMate 3 LVAD patients, interim analysis of the ApixiVAD trial, a randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2025.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}